About the company
 

CliniSense is a new startup corporation, located in Silicon Valley, California.  The company is focused on developing improved technology for stability and shelf-life monitoring.  Although we are primarily focused on the biotechnology, defense, and medical fields, our technology is general purpose, and we welcome customers from any area.

Full service consulting:

We have much experience with biochemistry, medical instrumentation, software design, and FDA regulations.  In addition to licensing LifeTrack IP, we provide a range of consulting services designed to get you up and running as quickly as possible.  These services include:

  • Help with FMEA analysis

  • Help determine the best stability model for your application

  • Help with embedded software design

  • Help design and implement suitable V&V experiments

  • Help with regulatory interaction and submissions

 

Travel policy

We will be happy to visit your company and give presentations and demonstrations.  However since we are a new startup, we need to focus our resources and energy on the most interested potential customers.  Thus our policy is to request reimbursement for travel expenses.  This helps us distinguish high interest from casual interest. 

Contact information

CliniSense, Corp., 15466 Los Gatos Blvd., Suite 109-355, Los Gatos, CA  95032.  Telephone: (408) 348-1495     Fax:  (408) 399-9705   Email:  admin@clinisense.com

 

Founder and CEO:  Stephen E. Zweig, Ph.D.

Dr. Zweig has over twenty years experience in biotechnology.  He founded Avocet Medical, Inc. in 1991, served as CEO through 1997, and Chairman through 2001.  Avocet developed the AvoSureTM home CoumadinTM monitoring meter, which pioneered new treatments for thrombosis in the US and Europe.  Its innovative dry-reagent protease-substrate chemistry and miniaturized fluorescent detector technology won an AAMI award in 1997, and has recently been acquired by Beckman-Coulter.  

In addition to stability monitoring technology, Dr. Zweig also works and consults in biosensors (molecular pathways), medical diagnostics (2diabetes.com), telemedicine (controlbot.com) and bioengineering patents.

Dr. Zweig received his Ph.D. in biochemistry from UCSD in 1980.  He was an assistant professor in pharmacology at Baylor College of Medicine, and an Arthritis Foundation postdoctoral fellow at NIH.  Dr. Zweig has also held management positions at Bayer Diagnostics, and LifeScan, a Johnson and Johnson company.

Dr. Zweig is an advisor to the College of Creative Studies at UCSB.                

Applications Biotech Corporate Devices Downloads IP Orders RFID Technology Vaccine Home




image
image